Spire Health Presents Interim Results on Anticipating Patient Hospitalizations using Industry’s Leading Remote Respiration Monitor
SAN FRANCISCO,CA – May 14, 2021 -- Spire Health, the leading provider of respiratory remote patient monitoring (RPM), today announced interim results from a clinical trial demonstrating the predictive capabilities and long-term patient adherence of theSpire RPM system. The results will be presented in two ePosters at the 2021 ATS International Conference, held virtually from May 14-19th.
The non-interventional study asked late-stage COPD patients located across the United States to wear Spire Health’s proprietary garment-adhered sensor, Health Tag, for 9 months in order to retrospectively examine usage and data patterns collected. Spire Health Tags are the only commercial solution for long term, continuous monitoring of respiratory effort. The 100% passive sensor form factor does not require any interaction or engagement from patients.
The first poster, Validation of Pre-Hospitalization Notification Performance Using Novelty Detection of Respiratory Force in COPD (ATS Session: TP037), describing the performance of a machine learning model trained on data from the study, showed that the model was able to reliably detect subtle changes in respiratory patterns on average 7 days before patients were hospitalized due to acute exacerbations of COPD.
“Anticipating severe exacerbations 7 days ahead of time is tremendously exciting for the future of COPD care,” said Neema Moraveji, Ph.D., Chief Science Officer of Spire Health, a co-author and principal investigator of the study. “It demonstrates the potential of pairing RPM with a robust sensor able to collect detailed respiratory data over extended periods of time. This dataset just hasn’t existed before. It’s new territory.”
The second poster, Evaluation of Long-Term Adherence to a Garment-Adhered Cardiorespiratory Monitor in Patients with COPD (ATS Session: TP015), analyzing adherence to the Health Tags during the same study, shows long term daily adherence rates of 80.4%, a significant improvement from traditional wrist-worn and clip-based devices.
The abstracts are currently available to view on the ATS website.
About Spire Health
Spire Health is the leading digital healthcare company for continuous respiratory monitoring and actionable feedback. The Spire Health Tag enables remote patient monitoring with unparalleled adherence and clinical-grade accuracy. Spire Health’s remote patient monitoring approach has the potential to identify and predict health events, enable early interventions, and prevent hospital admissions. Spire is backed by leading medical health investors and has received a grant from the US Department of Health and Human Services. For more information visit: www.spirehealth.com
Note: Spire Health Tags are general wellness devices that are intended to promote a healthy lifestyle and reduce the impact of chronic diseases such as COPD. Spire Health is currently pursuing FDA clearance for a future version of Health Tags for expanded remote patient monitoring applications.